Free Trial

DF Dent & Co. Inc. Sells 15,150 Shares of Exponent, Inc. (NASDAQ:EXPO)

Exponent logo with Business Services background

DF Dent & Co. Inc. decreased its position in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 6.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 210,244 shares of the business services provider's stock after selling 15,150 shares during the period. DF Dent & Co. Inc. owned about 0.41% of Exponent worth $18,733,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Exponent by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 5,345,503 shares of the business services provider's stock valued at $476,284,000 after purchasing an additional 67,296 shares in the last quarter. State Street Corp increased its holdings in shares of Exponent by 0.7% during the third quarter. State Street Corp now owns 1,840,313 shares of the business services provider's stock worth $212,151,000 after buying an additional 13,644 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Exponent by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 1,519,584 shares of the business services provider's stock valued at $135,419,000 after acquiring an additional 13,932 shares during the last quarter. JPMorgan Chase & Co. increased its holdings in Exponent by 63.6% in the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider's stock worth $72,701,000 after purchasing an additional 245,086 shares in the last quarter. Finally, Raymond James Financial Inc. bought a new position in Exponent in the fourth quarter valued at about $55,131,000. 92.37% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Exponent news, VP Richard Reiss sold 1,736 shares of the stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the transaction, the vice president now owns 1,800 shares in the company, valued at approximately $154,674. This represents a 49.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 2.10% of the stock is currently owned by company insiders.

Exponent Stock Performance

Shares of NASDAQ:EXPO traded up $0.04 during midday trading on Tuesday, hitting $76.92. 69,659 shares of the stock were exchanged, compared to its average volume of 237,170. The business's 50-day moving average price is $85.16 and its 200 day moving average price is $94.41. The stock has a market capitalization of $3.91 billion, a price-to-earnings ratio of 36.40 and a beta of 0.84. Exponent, Inc. has a 12 month low of $73.83 and a 12 month high of $115.75.

Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 EPS for the quarter, beating analysts' consensus estimates of $0.40 by $0.06. Exponent had a return on equity of 27.27% and a net margin of 19.52%. During the same period last year, the firm posted $0.41 EPS. As a group, sell-side analysts expect that Exponent, Inc. will post 1.98 EPS for the current year.

Exponent Profile

(Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

See Also

Institutional Ownership by Quarter for Exponent (NASDAQ:EXPO)

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market
5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines